SuperMAB on trial.
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans
D000911:Antibodies, Monoclonal